In this episode Michael Kruidenier chats with Michael O'Donoghue the Head of Site in New Hampshire US, where Quay's latest 50,000 sq ft facility is preparing for pharmaceutical development and clinical manufacturing.

Episode 6 - What to expect from Quay's up-coming webinar on Lipid based drug delivery

Nov 18th, 2020 24m 32s

In this episode, Chris Davies from Oxford Global discusses with Maura McArdle how Covid has changed how Quay reaches out to potential new clients and what to expect from Quay's up-coming webinar on Lipid based drug delivery.

Episode 5 - Whats Involved in a Typical Pharmaceutical Development for Clinical Trials.

Nov 3rd, 2020 21m 46s

In this episode Maura McArdle and Audrey Vardy from Quay Pharma, discuss what is involved in a typical pharmaceutical development for clinical trials and what differentiates Quay Pharma from other CDMO's.

Episode 4 - The New & Emerging Virtual Conference World

Oct 5th, 2020 38m 39s

In this episode, Dr. Ivan Langan & Michael Kruidenier from Quay talk to Adam Andersen from Informa Markets. They discuss how they are adapting to Covid-19 and the new and emerging virtual conference world.

Episode 3 - The Knowledge Transfer Partnership (KTP) programme

Sep 1st, 2020 32m 48s

In this episode, Audrey Vardy talks to Mike Card a KTP Advisor about the Knowledge Transfer Partnership programme.

Episode 2 - Quay Pharma's Pre Clinical Service and Expertise

Jul 28th, 2020 16m 50s

Maura McArdle and Audrey Vardy share a discussion on Quay's Pre Clinical service and expertise.

Episode 1 - An Introduction to Quay Pharma

Jun 24th, 2020 33m 53s

Dr. Ivan Langan and Michael Kruidenier share a discussion on Quay's heritage, what sets them apart, and their unique positions in Live Biotherapeutics.

Rate